Skip to main content
TipRanks
Go Ultimate75% OFF

Establishment Labs Holdings (3E0) Stock Price & Analysis

1 Followers

3E0 Stock Chart & Stats

€61.38-€0.94(-1.51%)
At close: 5:30 PM GMT+1
€55€60Sep 14Oct 14Oct 19Nov 12
Day’s Range
EUR 61.38 - EUR 61.74
52-Week Range
EUR 37.60 - EUR 83.28
Previous Close
EUR 62.32
Volume
N/A
Average Volume (3M)
20
Market Cap
EUR 1.91B
Enterprise Value
EUR 2.15B
Total Cash (Recent Filing)
EUR 75.81M
Total Debt (Recent Filing)
EUR 269.53M
Price to Earnings (P/E)
―
Beta
0.67
Next Earnings
Mar 02, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

U.S. And International Revenue Growth

Strong growth across both the U.S. and international businesses indicates expanding market reach rather than dependence on one geography. Continued account gains and international expansion can support durable revenue growth as Motiva adoption and procedure volumes increase over the next several quarters.

Improving Operating Leverage And Margins

The sharp improvement in adjusted EBITDA margin and operating expense efficiency shows that revenue growth is beginning to translate into operating leverage. If maintained, this can strengthen earnings quality, reduce the funding burden of expansion, and support the path toward sustainable profitability.

Motiva And Minimally Invasive Product Adoption

High reorder rates and rising surgeon utilization provide evidence of recurring product adoption rather than solely new-account demand. Rapid growth in minimally invasive products also broadens the portfolio and may deepen surgeon engagement, supporting longer-term share gains and revenue diversification.

Bears Say

Persistent GAAP Losses

The company has not yet converted strong gross margins and improving revenue into sustainable GAAP earnings. Continued losses constrain internally generated capital, increase reliance on external financing, and leave execution vulnerable if operating expenses do not scale efficiently with growth.

Highly Leveraged Capital Structure

Very high leverage reduces financial flexibility and leaves the company more dependent on improving profitability to stabilize its balance sheet. A thin equity cushion can limit investment choices, increase sensitivity to operating setbacks, and make future growth financing more consequential.

Reconstruction Approval And Hospital Adoption Timing

The reconstruction opportunity may take longer to contribute because regulatory approval is incomplete and hospital committee reviews can delay commercial adoption. This creates uncertainty around the timing of a potentially important growth channel and could push meaningful revenue contribution into the back half of 2027.

Establishment Labs Holdings News

3E0 FAQ

What was Establishment Labs Holdings’s price range in the past 12 months?
Establishment Labs Holdings lowest stock price was €37.60 and its highest was €83.28 in the past 12 months.
What is Establishment Labs Holdings’s market cap?
Establishment Labs Holdings’s market cap is €1.91B.
When is Establishment Labs Holdings’s upcoming earnings report date?
Establishment Labs Holdings’s next earnings report is estimated for Mar 02, 2027 (not yet confirmed), which is in 106 days.
How were Establishment Labs Holdings’s earnings last quarter?
Establishment Labs Holdings released its earnings results on Oct 29, 2026. The company reported -€0.313 earnings per share for the quarter, missing the consensus estimate of -€0.23 by -€0.083.
Is Establishment Labs Holdings overvalued?
According to Wall Street analysts Establishment Labs Holdings’s price is currently Undervalued.
Does Establishment Labs Holdings pay dividends?
Establishment Labs Holdings does not currently pay dividends.
What is Establishment Labs Holdings’s EPS estimate?
Establishment Labs Holdings’s EPS estimate is -0.17.
How many shares outstanding does Establishment Labs Holdings have?
Establishment Labs Holdings has 29,823,470 shares outstanding.
What happened to Establishment Labs Holdings’s price movement after its last earnings report?
Establishment Labs Holdings reported an EPS of -€0.313 in its last earnings report, missing expectations of -€0.23. Following the earnings report the stock price went up 1.071%.
Which hedge fund is a major shareholder of Establishment Labs Holdings?
Hedge funds hold Establishment Labs Holdings shares: the largest hedge-fund position in Establishment Labs Holdings is 484,416,081 shares, and hedge funds increased their holdings by 119.3K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology